1199618-56-8

Basic information

• Product Name: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide besylate
• Synonyms: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide besylate
• CAS NO: 1199618-56-8
• Molecular Weight: 623.009
• Mol File: 1199618-56-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide besylate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide besylate(1199618-56-8)
• EPA Substance Registry System: 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide besylate(1199618-56-8)

Safety Data

• Hazardous Substances Data: 1199618-56-8(Hazardous Substances Data)

Upstream product

• 284462-37-9 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide 
• 327-78-6 4-chloro-3-(trifluoromethyl)phenyl isocyanate 
• 98-11-3 benzenesulfonic acid 
• 284461-73-0 sorafenib 

Relevant articles and documents

Sorafenib hemicamsylate and processes for preparation thereof

The present invention relates to: novel sorafenib hemi camsylate salt for treating cancer (chemical formula III); a novel crystalline form thereof; and a method for manufacturing the same. More specifically, the present invention relates to: hemi camsylate salt having high stability, solubility, and purity; a crystalline form thereof; and a method for manufacturing the same. The problem to be solved by the present invention is to provide novel sorafenib salt which is easy to make various preparations, and the method for manufacturing novel salt.COPYRIGHT KIPO 2020